ABSTRACT
The increasing demand for cost-efficient and user-friendly wearable electronic devices has led to the development of stretchable electronics that are both cost-effective and capable of maintaining sustained adhesion and electrical performance under duress. This study reports on a novel physically crosslinked poly(vinyl alcohol) (PVA)-based hydrogel that serves as a transparent, strain-sensing skin adhesive for motion monitoring. By incorporating Zn2+ into the ice-templated PVA gel, a densified amorphous structure is observed through optical and scanning electron microscopy, and it is found that the material can stretch up to 800% strain according to tensile tests. Fabrication in a binary glycerol:water solvent results in electrical resistance in the kΩ range, a gauge factor of 0.84, and ionic conductivity on the scale of 10-4 S cm-1 , making it a potentially low-cost candidate for a stretchable electronic material. This study characterizes the relationship between improved electrical performance and polymer-polymer interactions through spectroscopic techniques, which play a role in the transport of ionic species through the material.
Subject(s)
Polyvinyl Alcohol , Wearable Electronic Devices , Polymers , Motion , Electric Conductivity , Hydrogels/chemistry , IonsABSTRACT
Catalytic drugs based on target-selective artificial proteases have been proposed as a new paradigm in drug design. Peptide-cleavage agents selective for pathogenic proteins of Alzheimer's disease, type 2 diabetes mellitus or Parkinson's disease have been prepared using the Co(III) aqua complex (Co(III)cyclen) of 1,4,7,10-tetraazacyclododecane as the catalytic center. In the present study, the Co(III) aqua complex (Co(III)oxacyclen) of 1-oxa-4,7,10-triazacyclododecane was examined in search of an improved catalytic center for peptide-cleavage agents. An X-ray crystallographic study of [Co(oxacyclen)(CO(3))](ClO(4)), titration of Co(III)oxacyclen, and kinetic studies on the cleavage of albumin, gamma-globulin, lysozyme, and myoglobin by Co(III)oxacyclen were carried out. Considerably higher proteolytic activity was observed for Co(III)oxacyclen in comparison with Co(III)cyclen, indicating that better target-selective artificial metalloproteases would be obtained using Co(III)oxacyclen as the catalytic center. The improved proteolytic activity was attributed to either steric effects or the increased Lewis acidity of the Co(III) center. The kinetic data also predicted that side effects due to the cleavage of nontarget proteins by a catalytic drug based on Co(III)oxacyclen would be insignificant.
